Anons enpòtan

Mizajou Règleman Non-Diskriminasyon

Boston Medical Center Health System konfòm ak lwa federal dwa sivil ki aplikab yo epi li pa fè diskriminasyon sou baz laj, ras, koulè, orijin nasyonal (ki gen ladan konpetans limite angle ak lang prensipal), relijyon, kilti, andikap fizik oswa mantal, sitiyasyon sosyoekonomik, sèks, oryantasyon seksyèl ak idantite sèks ak/oswa ekspresyon. BMCHS bay èd ak sèvis gratis pou moun ki gen andikap ak sèvis lang gratis pou moun ki gen lang prensipal pa angle.

Pou li tout Deklarasyon sou Non Diskriminasyon nou an, klike isit la.

BARC is an IRB-approved, fee-for-service archive of biospecimens. Our mission is to collect high quality samples of normal and diseased human material with appropriate clinical annotation and make these biospecimens available to qualified researchers. All subjects have given consent for these biospecimens to be used in broad applications of research, while the BARC is charged with protecting privacy and confidentiality of all participants.

All biospecimens collected from medical procedures at BMC have been procured from patients under rigorous quality management, processed and stored using NCI Best Practices.

  • Tissue samples are frozen and/or blocked in paraffin, with many having matching plasma samples
  • Can work with investigators to get prospective samples if retrospective samples will not work
  • BARC Oversight Committee will review and approve application to ensure feasibility

DISEASE AND TISSUE TYPES REPRESENTED:

Colon

  • IBD
  • Rectal Cancer
  • Colon Cancer

Tonsils

  • Obstructive Sleep Apnea
  • Tonsillitis

Parathyroid

  • Parathyroid Adenoma

Stomach

  • Stomach Cancer

Prostate

  • Prostate Cancer

Uterus

  • Uterine Cancer

Lung

  • Squamous Cell Carcinoma
  • Adenocarcinoma

Ovary

  • Ovarian Cancer

Thyroid

  • Papillary Carcinomas

Kidney

  • Papillary Renal Cell Carcinoma
  • Renal Cell Carcinoma
  • Clear Cell Carcinoma

Breast

  • Ductal Carcinoma In Situ
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma